PCSK9 Inhibitors in Heart Transplant Patients: Safety, Efficacy, and Angiographic Correlates

Proprotein Convertase Subtilisin/Kexin type-9 inhibitors

Source: Journal of Cardiac Failure - March 19, 2021 Category: Cardiology Authors: Yasser Sammour, Christopher DeZorzi, Bethany A Austin, A Michael Borkon, Mark P Everley, Timothy J Fendler, Taiyeb M Khumri, Stephanie L Lawhorn, Michael E Nassif, Deepthi Vodnala, Anthony Magalski, Andrew C Kao, Brett W. Sperry Source Type: research